Cyclic nucleotide phosphodiesterase inhibitors prevent aggregation of human platelets by raising cyclic amp and reducing cytoplasmic free calcium mobilization

Cazenave, 1984, Current treatment for thrombotic diseases, Agent Action (suppl.), 15, 24 Feinstein, 1985, Calcium and cyclic AMP : antagonist modulators of platelet function, 237 Feinstein, 1983, The cytoplasmic concentration of free clacium in platelets is controlled by stimulators of cyclic AMP production, Biochem. Biophys. Res. Commun., 113, 598, 10.1016/0006-291X(83)91768-0 Zavoico, 1984, Cytoplasmic Ca++ in platelet is controlled by cyclic AMP : antagonism between stimulators and inhibitors of adenylate cyclase, Biochem. Biophys. Res. Commun., 120, 579, 10.1016/0006-291X(84)91294-4 Yamanishi, 1983, Effect of cyclic AMP on cytoplasmic free calcium in human platelets stimulated by thrombin : direct measurements with quin 2, Thromb. Res., 32, 183, 10.1016/0049-3848(83)90029-4 Beretz, 1982, Role of cyclic AMP in the inhibition of human platelet aggregation by quercetin, a flavonoid that potentiates the effects of prostacyclin, Biochem. Pharmacol., 31, 3597, 10.1016/0006-2952(82)90581-0 Muggli, 1985, 7-bromo-1,5-dihydro-3,6-dimethylimidazo (2,1-b) quinazolin-2(3H) -one (RO 15 - 2041) , a potent antithrombotic agent that selectively inhibits platelet cyclic-AMP-phosphodiesterase, J. Pharmacol. Exp. Ther., 235, 212 Haslam, 1982, Roles of cyclic AMP and cyclic GMP in the inhibition of platelet function by nitroprusside and phosphodiesterase inhibitors, Circulation, 66, II Cazenave, 1983, L'agrégation plaquettaire: outil d'investigation clinique et d'Étude pharmacologique, 41, 167 Rink, 1985, Using quin 2 in cell suspensions, Cell Calcium, 6, 133, 10.1016/0143-4160(85)90040-5 Hallam, 1985, Responses to adenosine diphosphate in human platelets loaded with the fluorescent calcium indicator quin 2, J. Physiol., 368, 131, 10.1113/jphysiol.1985.sp015850 Beretz, 1986, Inhibition of human cyclic AMP phosphodiesterase and of platelet aggregation by a hemisynthetic flavonoid amentoflavone hexaacetate, Biochem. Pharmacol., 35, 257, 10.1016/0006-2952(86)90523-X Pannocchia, 1985, Cyclic AMP inhibits platelet activation independently of its effect on cytosolic free calcium, Biochem. Biophys. Res. Commun., 127, 339, 10.1016/S0006-291X(85)80164-9 Ruppert, 1982, HL 725, an extremely potent inhibitor of platelet phosphodiesterase and induced platelet aggregation in vitro, Life Sci., 31, 2037, 10.1016/0024-3205(82)90095-9 Lugnier, 1983, Tissue and substrate specificity of inhibition by alkoxy-aryl-lactams of platelet and arterial smooth muscle cyclic nucleotide phosphodiesterases relationship to pharmacological activity, Biochem. Biophys. Res. Commun., 113, 954, 10.1016/0006-291X(83)91091-4 Hagiwara, 1984, Effect of 1-(3-chloroanilo)-4-phenylphtalazine (MY-5445), a specific inhibitor of cyclic GMP phosphodiesterase, on human platelet aggregation, J. Pharmacol. Exp. Ther., 228, 467 Hemmendinger, 1984, Inhibition of human platelet cAMP-phosphodiesterase (PDE) by HL 725, a potent PDE inhibitor which is almost as active on platelet function as prostacyclin, 233 Kinlough-Rathbone, 1977, Mechanisms of platelet shape change, aggregation and release induced by collagen, thrombin or A 23187, J. Lab. Clin. Med., 90, 707 Jakobs, 1978, Inhibition of platelet adenylate cyclase by epinephrine requires GTP, FEBS Lett., 85, 167, 10.1016/0014-5793(78)81272-1 Lanza, 1985, Studies of alpha2-adrenergic receptors of intact and functional washed human platelets by binding of 3H-dihydroergocryptine and 3H-yohimbine, 54, 402 Bushfield, 1985, Inhibition of platelet-activating-factor-induced human platelet activation by prostaglandin D2, Biochem. J., 232, 267, 10.1042/bj2320267 Ware, 1985, Aequorin detects increased cytoplasmic calcium in platelets stimulated with phorbol ester or diacylglycerol, Biochem. Biophys. Res. Commun., 133, 98, 10.1016/0006-291X(85)91846-7